LLY - Eli Lilly and Company

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
22,644,100
24,555,700
22,871,300
21,222,100
19,958,700
Cost of Revenue
5,032,300
6,430,000
6,070,200
5,654,900
5,037,200
Gross Profit
17,611,800
18,125,700
16,801,100
15,567,200
14,921,500
Operating Expenses
Research Development
5,467,400
5,307,100
5,281,800
5,243,900
4,796,400
Selling General and Administrative
6,309,300
6,389,700
6,588,100
6,452,000
6,533,000
Total Operating Expenses
11,776,700
11,696,800
11,869,900
11,695,900
11,329,400
Operating Income or Loss
5,835,100
6,428,900
4,931,200
3,871,300
3,592,100
Interest Expense
-
272,100
225,000
185,200
161,200
Total Other Income/Expenses Net
-1,020,200
-2,522,400
-2,676,100
-420,800
-727,900
Income Before Tax
4,541,700
3,795,700
2,197,400
3,374,000
2,790,000
Income Tax Expense
274,500
563,700
2,401,500
636,400
381,600
Income from Continuing Operations
4,267,200
3,232,000
-204,100
2,737,600
2,408,400
Net Income
7,947,700
3,232,000
-204,100
2,737,600
2,408,400
Net Income available to common shareholders
7,947,700
3,232,000
-204,100
2,737,600
2,408,400
Reported EPS
Basic
-
3.06
-0.19
2.49
2.18
Diluted
-
3.06
-0.19
2.49
2.18
Weighted average shares outstanding
Basic
-
1,057,639
1,052,023
1,100,875
1,105,267
Diluted
-
1,057,639
1,052,023
1,100,875
1,105,267
EBITDA
-
5,676,800
3,989,700
5,055,800
3,592,100